Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Centro di Terapia Cellulare Gilberto Lanzani is a specialized GMP-certified facility located within the ASST Papa Giovanni XXIII in Bergamo, Italy. It focuses on the development and production of Advanced Therapy Medicinal Products (ATMPs) for clinical use, particularly in the fields of hematology and oncology. The center is renowned for its expertise in bone marrow transplantation support, mesenchymal stem cell production, and the generation of virus-specific T cells. It serves as a critical hub for translational research, bridging the gap between laboratory discovery and patient treatment through rigorous quality standards. The facility is authorized by the Italian Medicines Agency (AIFA) for the production of cell-based therapies for multicenter clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centro di Terapia Cellulare Gilberto Lanzani.